Idera Pharmaceuticals (IDRA) PT Lowered to $4 at JMP Securities
Tweet Send to a Friend
JMP Securities lowered its price target on Idera Pharmaceuticals (NASDAQ: IDRA) to $4.00 (from $8.00) while maintaining a Market Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
